Investigational Site Number : 5280002

Rotterdam 3045 PM

3 studies enrolling now · 7 studies all time

What they study most

Chronic Graft Versus Host Disease, Chronic Inflammatory Demyelinating Polyradiculoneuropathy, Chronic Kidney Diseases, Chronic Obstructive Pulmonary Disease, Dermatitis Atopic, Heart Failure, Multiple Sclerosis, Polyneuropathy, Inflammatory Demyelinating, Chronic, Sickle Cell Disease, Type 2 Diabetes Mellitus

Studies at this site

• The Efficacy and Safety of Rilzabrutinib in Participants Aged 10 to 65 Years With Sickle-cell Disease — Recruiting now
• A Study to Test the Effects and Safety of Riliprubart in People With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) for Which the Usual Treatments do Not Work — Recruiting now
• A Study to Investigate Airway Inflammation With Dupilumab Subcutaneously in Participants Aged ≥40 to ≤85 Years With Chronic Obstructive Pulmonary Disease. — Recruiting now
• Efficacy and Safety Study of Frexalimab (SAR441344) in Adults With Nonrelapsing Secondary Progressive Multiple Sclerosis — Running, not enrolling
• A Study to Test an Oral Medicine, Belumosudil, in Combination With Corticosteroids in Participants at Least 12 Years of Age With Newly Diagnosed Chronic Graft Versus Host Disease. — Running, not enrolling
• Observational Evaluation of Atopic Dermatitis in Pediatric Patients — Running, not enrolling
• Effect of Sotagliflozin on Cardiovascular and Renal Events in Participants With Type 2 Diabetes and Moderate Renal Impairment Who Are at Cardiovascular Risk — Stopped early